Are there common genetic and environmental factors behind the endophenotypes associated with the metabolic syndrome? by Benyamin, B et al.
ARTICLE
Are there common genetic and environmental factors behind
the endophenotypes associated with the metabolic syndrome?
B. Benyamin & T. I. A. Sørensen & K. Schousboe &
M. Fenger & P. M. Visscher & K. O. Kyvik
Received: 21 August 2006 /Accepted: 5 June 2007 /Published online: 12 July 2007
# Springer-Verlag 2007
Abstract
Aims/hypothesis The cluster of obesity, insulin resistance,
dyslipidaemia and hypertension, called the metabolic
syndrome, has been suggested as a risk factor for
cardiovascular disease and type 2 diabetes. The aim of the
present study was to evaluate whether there are common
genetic and environmental factors influencing this cluster in
a general population of twin pairs.
Materials and methods A multivariate genetic analysis was
performed on nine endophenotypes associated with the
metabolic syndrome from 625 adult twin pairs of the
GEMINAKAR study of the Danish Twin Registry.
Results All endophenotypes showed moderate to high
heritability (0.31–0.69) and small common environmental
variance (0.05–0.21). In general, genetic and phenotypic
correlations between the endophenotypes were strong only
within sets of physiologically similar endophenotypes, but
weak to moderate for other pairs of endophenotypes.
However, moderate correlations between insulin resistance
indices and either obesity-related endophenotypes or
triacylglycerol levels indicated that some common genetic
backgrounds are shared between those components.
Conclusions/interpretation We demonstrated that, in a
general population, the endophenotypes associated with
the metabolic syndrome apparently do not share a substan-
tial common genetic or familial environmental background.
Keywords Correlation . Genetic . Heritability . Insulin
resistance .Metabolic syndrome .Multivariate . Obesity
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A additive genetic variance
a2 the proportion of phenotypic variance
explained by additive genetic effects
AIR acute insulin response
BIGTT OGTT-derived index
C common environmental variance shared
by a twin pair
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D dominance genetic variance
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E environmental variance specific to
individuals
e2 the proportion of phenotypic variance
explained by specific individual
environmental effects
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Introduction
The metabolic syndrome or insulin resistance syndrome is
characterised by clustering of a group of symptoms related
to insulin resistance, impaired glucose tolerance or diabetes,
obesity, hypertension and dyslipidaemia (raised triacylglyc-
erol [TAG] level and low HDL) [1–3]. The clustering of
these symptoms has been suggested to be a better predictor
of type 2 diabetes [4] and cardiovascular disease [5, 6] than
expected from the individual components. Currently, the
prevalence of this syndrome is high, not only in developed
countries but also in developing countries [7]. In the USA,
about 25% of the adult population have been identified as
having the metabolic syndrome [8].
Growing evidence suggests that variation in the individ-
ual components of the metabolic syndrome is in part due to
genetic effects. A wide range of heritabilities (mostly mod-
erate to high) have been estimated for obesity traits (mean:
0.55; range: 0.37–0.80) [9–14]; insulin-related traits (mean:
0.38; range: 0.08–0.75) [9–11, 13–16]; BP (mean: 0.41;
range: 0.16–0.76) [9–13] and lipid traits (mean: 0.46;
range: 0.20–0.70) [9–13]. However, the underlying mech-
anism of the clustering of these characteristics in an
individual remains unclear [17].
Correlations between insulin-related endophenotypes
and obesity endophenotypes have been previously estimat-
ed to be moderate or high [16, 18, 19], while correlations
between other metabolic syndrome endophenotypes have
been found to be weak or moderate [12, 16, 19–21]. These
correlations have surprisingly often been interpreted as
strong evidence for a common factor underlying the meta-
bolic syndrome.
In a joint statement from the American Diabetes
Association and the European Association for the Study
of Diabetes, Kahn et al. [22] raised several provocative
questions, including whether the metabolic syndrome is
indeed a syndrome. This question was raised due to the
findings that correlations between the metabolic syndrome
endophenotypes were weak to moderate. Also, factor
analyses have suggested that more than one pathophysio-
logical process underlies the syndrome, where more than
one-third of total variance in the clustering of the metabolic
syndrome components was unexplained by latent factors
identified from factor analyses [22].
Twins from the Danish Twin Registry have been used to
estimate the heritability of each separate endophenotype
associated with the metabolic syndrome in old twins born
between 1921 and 1930 (40 for the county of Funen) and
recently, based on 625 twin pairs from the study ‘The
importance of genes, familiar and common environment for
the development of insulin resistance, abdominal adiposity
and cardiovascular risk factors’ (GEMINAKAR) [14, 23].
The aim of the present study was to quantify genetic and
environmental (co)variation between these endophenotypes
in the GEMINAKAR cohort. Multivariate genetic analysis
was employed to provide a complete and objective
description of the underlying genetic and environmental
architecture of the relationship between traits. In addition to
partitioning the phenotypic variance into genetic and
environmental components, phenotypic covariance between
the traits was partitioned in a similar fashion. To elucidate
the underlying genetic and environmental relationships
between these endophenotypes in general populations,
phenotypic data on 17 endophenotypes associated with
the metabolic syndrome were analysed.
Materials and methods
Participants The data analysed in the present study were
part of the GEMINAKAR study [14, 23]. The study is a
nationwide Danish project investigating the genetic epide-
miology of a wide variety of phenotypes among Danish
twins, including endophenotypes of the metabolic syn-
drome [14, 23]. The twins were recruited from two cohorts
of the nationwide, population-based Danish Twin Registry.
Cohort I covers the birth cohorts 1931–1952, while cohort
II covers birth cohorts 1953–1982. Invitations to take part
in a full day clinical investigation were sent to 2,585
randomly chosen twin pairs who fulfilled the criteria that at
least one twin should live within 100 km from one of the
two clinical investigation sites (Odense and Copenhagen)
and the pair should not be taking part in other studies at the
same time. Cohort II was furthermore chosen based on
previous self-report of being healthy. The invitation
contained detailed information about the study and its
exclusion criteria (i.e. known diabetes or cardiovascular
disease, conditions making a progressive maximal bicycle
test impossible, pregnancy and breast-feeding). A reply
coupon was enclosed for the twins to give information
about their present health status and to either consent to or
decline telephone contact. If one twin partner in a pair did
not respond or was not willing to participate, the pair as
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such was excluded. In 1,098 complete twin pairs (42.5%)
both were willing and able to participate. A stratified
sample of 756 twin pairs underwent an extensive full day
clinical examination of a variety of phenotypes. The main
focus was on phenotypes related to insulin resistance,
obesity and cardiovascular risk factors. The sample includ-
ed 311 monozygotic (MZ), 314 same-sex dizygotic (DZ)
and 131 opposite-sex dizygotic twin pairs with a mean age
of 38 years (range 18–67 years). In this study, only same-
sex twins were analysed (625 twin pairs).
The examinations were run in parallel at The Danish
Twin Registry in Odense and at The Institute of Preventive
Medicine in Copenhagen from 1997 to 2000. The twins in a
pair were examined on the same day. DNA-based micro-
satellite markers (AmpFISTR Profiler Plus Kit; PE Applied
Biosystems, Perkin Elmer, Foster City, CA, USA ) were used
to determine zygosity of the twins. The study was approved
by all the Danish regional scientific ethical committees, the
Danish Data Protection Agency and conducted according to
the principles of the Helsinki Declaration.
Phenotypic studies In this study, 13 endophenotypes and
four composite phenotypes related to the metabolic syn-
drome were analysed. The endophenotypes included: BMI;
waist circumference; 0 (fasting), 30 and 120 min glucose
and insulin (fasting, 30 and 120 min) levels; systolic and
diastolic BP; HDL and LDL lipoproteins; and TAG. From
some of these endophenotypes, four composite phenotypes
were derived to obtain two indices for each measure of
insulin resistance (OGTT-derived index [BIGTT] of insulin
sensitivity [SI]|0–30–120 [24] and homeostasis model assessment
[HOMA] of insulin resistance [HOMA-IR] [25]) and beta cell
function (BIGTT of acute insulin response [AIR]0–30–120 [24]
and HOMA of beta cell function [HOMA-%B] [25]). The
BIGTT indices are new OGTT-derived indices of insulin
sensitivity and beta cell function. They have been shown to
correlate highly with IVGTT-derived measures and to
perform better in predicting insulin resistance and beta cell
function than other measures [24].
BMI was calculated as weight (kg) divided by square of
height (m), where weight was measured using a standing
beam scale to the nearest 0.1 kg and height was measured
using a vertical scale with a horizontal moving headboard
to the nearest centimetre. The measure (cm) of midway
between the lowest rib and iliac crest was defined as waist
circumference [23]. A WHO standard OGTT was carried
out after a 10 to 12 h overnight fast. Blood was taken
before oral glucose ingestion and 30 and 120 min later; it
was then analysed using the glucose dehydrogenase
oxidation method. Then, a two-site, two-step, time-resolved
immunofluorometric assay was used to measure serum
insulin concentration [14]. Cholesterol, HDL and TAG
were measured on fasting blood samples by a colorimetric
method (VITROS; Johnson & Johnson, New Brunswick,
NJ, USA). LDL was calculated (Friedewald formula) by
subtracting HDL and (0.45 × TAG) from total cholesterol.
Systolic and diastolic BPs were measured after 30 min rest
using a conventional mercury sphygmomanometer and
hands-free stethoscope. Measurements were taken three
times and the mean was used for analysis.
BIGTT-SI|0–30–120 was calculated as:
exp
4:90 0:00402  I0½   0:000556 I30½ 
 0:00127  I120½   0:152 G0½   0:00871 G30½ 
 0:0373 G120½   0:145 Si½   0:0376 BMI½ 
0
@
1
A 24½ 
ð1Þ
BIGTT-AIR0–30–120 was calculated as:
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Si is an indicator of sex, with Si=0 for women and Si=1
for men; G stands for glucose and I for insulin with the
subscript value indicating the time (min).
HOMA was used to calculate insulin resistance and beta
cell function [26].
The phenotypic correlations (rP) between the various
indices of insulin resistance are presented in the Electronic
supplementary material (ESM) Table 1.
Statistical analyses Descriptive statistics of the data were
explored using SPSS version 13.0 for Windows (SPSS,
Chicago, IL, USA) to examine trait distributions (Table 1).
For endophenotypes showing a non-normal distribution,
including BMI, fasting glucose, 120 min glucose, fasting
insulin, 30 min insulin, 120 min insulin, HDL, TAG, HOMA-
IR, HOMA-%B and BIGTT-AIR, a 100 × natural logarithm
transformation was carried out. For each endophenotype,
individuals with a trait value more than 4 SD above or below
the mean (after sex and age adjustments) were removed.
Outlying families were detected using a standardised Mahal-
anobis distance (implemented in Mx statistical packages
[27]) to compute a z score for each family, taking into
account MZ and DZ similarity. Families with a z score of
more than 3 SD below or above the mean were removed. A
general linear model was fitted to test for the effects of sex
and zygosity on the endophenotypes. Twin correlations were
calculated after adjustment for age and sex effects.
By comparing the resemblance of MZ twin pairs to that of
DZ twin pairs, a twin design allows the phenotypic variance
of phenotypes to be partitioned into underlying additive
genetic variance (A), common environmental variance
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shared by a twin pair (C), dominance genetic variance (D)
and environmental variance specific to individuals (E). The
analysis assumes that both types of twins share the same
degree of common environmental experiences (the so-called
common environment assumption). In a twin design, D and
C are confounded, so they cannot be estimated simulta-
neously. An ACE model was selected in preference to an
ADE model, since MZ twin correlations were less than
twice those of DZ correlations (Table 2), which suggested,
when assuming no greater C effects than estimated in the
ACE model, that there is no dominance genetic effect.
Multivariate genetic analysis to partition the phenotypic
(co)variance between endophenotypes into A, C and E
components was performed using a maximum likelihood
method as implemented in Mx [27]. This analysis estimates
the proportion of phenotypic variance of individual endo-
phenotypes due to genetic and environmental variances, as
well as the genetic and environmental covariation between
endophenotypes. Since BIGTT measurements are functions
of other endophenotypes, only nine endophenotypes were
included in multivariate genetic analysis, namely BMI,
waist circumference, systolic BP, diastolic BP, HDL, LDL,
TAG, BIGTT-SI and BIGTT-AIR. For each endophenotype,
the standardised residuals after a general linear model cor-
rection for the effects of sex and age were used in the
Table 2 Twin intraclass correlations and their 95% CIs after
adjustment for age and sex effects
Endophenotypes MZ Same-sex DZ
BMI 0.71 (0.65–0.76) 0.47 (0.37–0.55)
Waist circumference 0.62 (0.55–0.68) 0.39 (0.29–0.48)
Glucose
Fasting 0.51 (0.41–0.59) 0.35 (0.25–0.44)
30 min 0.50 (0.41–0.58) 0.28 (0.17–0.38)
120 min 0.44 (0.35–0.53) 0.24 (0.13–0.34)
Insulin
Fasting 0.44 (0.35–0.53) 0.26 (0.15–0.36)
30 min 0.50 (0.41–0.58) 0.32 (0.21–0.41)
120 min 0.45 (0.35–0.53) 0.22 (0.11–0.33)
BP (mmHg)
Systolic 0.64 (0.57–0.70) 0.41 (0.31–0.50)
Diastolic 0.66 (0.59–0.72) 0.38 (0.28–0.47)
LDL 0.72 (0.66–0.77) 0.39 (0.28–0.48)
HDL 0.63 (0.55–0.69) 0.44 (0.34–0.53)
Triacylglycerol 0.44 (0.34–0.53) 0.33 (0.22–0.43)
BIGTT-SI 0.48 (0.39–0.57) 0.23 (0.12–0.34)
BIGTT-AIR 0.58 (0.50–0.65) 0.37 (0.26–0.47)
HOMA-IR 0.40 (0.30–0.49) 0.25 (0.14 –0.36)
HOMA-%B 0.50 (0.41–0.58) 0.36 (0.25–0.45)
Table 1 Metabolic syndrome endophenotypes by sex and zygosity after removal of outliers
Endophenotypes Sex Zygosity All Range
Men Women MZ DZ
Number of subjects
(range)
555–582 599–640 572–606 582–616 1,154–1,222
Age (years) 38.01 (11.04) 37.70 (10.48) 37.81 (10.99) 37.89 (10.51) 37.85 (10.75) 18–67
BMI (kg/m2) 24.89 (3.00) 23.95 (3.76) 24.43 (3.31) 24.36 (3.59) 24.40 (3.45) 16.09–38.58
Waist circumference (cm) 89.28 (8.75) 78.46 (9.49) 83.82 (10.52) 83.42 (10.72) 83.62 (10.62) 58–121
Glucose (mmol/l)
Fasting 4.87 (0.49) 4.70 (0.46) 4.76 (0.50) 4.79 (0.47) 4.78 (0.48) 3.2–7.6
30 min 8.65 (1.52) 8.27 (1.43) 8.41 (1.53) 8.49 (1.43) 8.45 (1.48) 3.6–14.7
120 min 5.89 (1.36) 6.39 (1.16) 6.23 (1.33) 6.07 (1.23) 6.15 (1.28) 2.5–13
Insulin (pmol/l)
Fasting 35.88 (17.38) 37.95 (19.15) 37.48 (18.16) 36.43 (18.52) 36.95 (18.34) 6–150
30 min 300.57 (191.13) 318.19 (175.18) 308.28 (163.01) 311.12 (201.33) 309.71 (183.17) 40–1,741
120 min 138.22 (115.13) 188.98 (124.62) 170.28 (122.29) 158.91 (123.06) 164.59 (122.75) 8–1,131
BP (mmHg)
Systolic 120.24 (13.16) 113.38 (13.17) 116.50 (13.95) 116.81 (13.26) 116.65 (13.60) 78.0–168.7
Diastolic 69.83 (10.44) 67.14 (10.24) 68.76 (10.66) 68.08 (10.17) 68.42 (10.42) 42.7–112.0
LDL (mmol/l) 3.31 (1.11) 3.23 (1.01) 3.23 (1.03) 3.31 (1.08) 3.27 (1.06) −0.6–7.4
HDL (mmol/l) 1.37 (0.40) 1.59 (0.44) 1.48 (0.43) 1.49 (0.44) 1.49 (0.43) 0.5–3.6
TAG (mmol/l) 1.33 (0.65) 1.17 (0.46) 1.26 (0.56) 1.23 (0.57) 1.25 (0.56) 0.2–4.9
BIGTT-SI 10.59 (3.23) 11.82 (3.73) 11.10 (3.43) 11.35 (3.66) 11.23 (3.55) 1.2–24.0
BIGTT-AIR 2,369.15
(1,377.43)
2,199.79
(1,215.31)
2,268.87
(1,064.07)
2,293.41
(1,493.49)
2,281.24
(1,298.01)
650.9–16,732.9
HOMA-IR 1.12 (0.57) 1.14 (0.61) 1.13 (0.56) 1.13 (0.62) 1.13 (0.59) 0.17–5.0
HOMA-%B 84.34 (52.38) 103.93 (72.05) 98.49 (68.25) 90.52 (59.43) 94.46 (64.04) 9.6–700.5
Values are mean (SD) and range as indicated.
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genetic analysis, because this was computationally much
more efficient.
Results
Descriptive statistics Descriptive statistics of the endophe-
notypes related to the metabolic syndrome are presented in
Table 1. Among nine endophenotypes included in the
multivariate genetic analysis, no significant mean differ-
ences between zygosity groups were observed for all
endophenotypes (p<0.05). Across sexes, mean differences
(p<0.05) were observed for most endophenotypes, except
for LDL. Therefore, in the multivariate genetic analysis, the
endophenotypes were adjusted for the effect of sex.
Based on overlapping 95% CIs, there was no sex-related
difference in MZ and DZ twin correlations for all
endophenotypes. Therefore, pooled estimates are shown in
Table 2. For all endophenotypes, MZ correlations were
consistently larger than those of DZ, suggesting that genetic
factors contributed to the phenotypic variation of the
metabolic syndrome endophenotypes. Indeed, the results
of statistical genetic modelling (described in the next
sections) confirmed that a significant part of the phenotypic
variation of most endophenotypes was due to genetic
factors. Furthermore, the pattern of MZ and DZ correla-
tions, in which MZ correlations were generally less than
twice those of DZ correlations, indicated that an ACE
model was more appropriate to explain the phenotypic
variations of the metabolic syndrome endophenotypes than
an ADE model.
Genetic analysis Multivariate genetic analysis of nine
endophenotypes was performed simultaneously in a single
analysis. The proportion of phenotypic variance of the
endophenotypes explained by additive genetic (a2, herita-
bility), common (c2) and individual specific (e2) environ-
mental effects from an ACE model are presented in Table 3.
Moderate to high heritability were estimated for all
endophenotypes (0.31–0.69). All endophenotypes had very
small C components (0.05–0.21).
Table 3 The proportion of phenotypic variance of endophenotypes related to the metabolic syndrome due to additive genetic effects (a2),
common environmental effects shared by twin pairs (c2) and specific individual environmental effects (e2) from multivariate analyses
Endophenotypes Variance components
a2 (95% CI) c2 (95% CI) e2 (95% CI)
BMI 0.59 (0.42–0.73) 0.15 (0.02–0.26) 0.26 (0.22–0.32)
Waist circumference 0.45 (0.26–0.55) 0.19 (0.05–0.32) 0.36 (0.31–0.43)
BP
Systolic 0.45 (0.26–0.64) 0.21 (0.04–0.38) 0.34 (0.29–0.40)
Diastolic 0.50 (0.31–0.59) 0.16 (0.02–0.22) 0.34 (0.29–0.41)
HDL 0.46 (0.28–0.62) 0.20 (0.07–0.35) 0.34 (0.28–0.41)
LDL 0.69 (0.54–0.77) 0.06 (0.00–0.20) 0.25 (0.21–0.30)
TAG 0.31 (0.10–0.51) 0.19 (0.03–0.36) 0.50 (0.42–0.59)
BIGTT-SI 0.48 (0.29–0.59) 0.05 (0.00–0.20) 0.47 (0.40–0.54)
BIGTT-AIR 0.48 (0.27–0.66) 0.14 (0.00–0.32) 0.38 (0.32–0.46)
Analysis was on the full ACE model.
Table 4 Pearson’s phenotypic correlations between endophenotypes associated with the metabolic syndrome
Endophenotypes BMI Waist circumference SBP DBP HDL LDL TAG BIGTT-SI
BMI
Waist circumference 0.85
BP
Systolic 0.26 0.23
Diastolic 0.23 0.21 0.69
HDL −0.14 −0.17 −0.02 0.02
LDL 0.10 0.13 0.10 0.11 −0.16
TAG 0.22 0.26 0.20 0.20 −0.21 0.22
BIGTT-SI −0.64 −0.57 −0.31 −0.29 0.14 −0.13 −0.39
BIGTT-AIR 0.45 0.39 0.12 0.12 −0.12 0.08 0.11 −0.43
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Phenotypic correlations between endophenotypes were
mostly weak to moderate, except for strong correlations
between the same groups of endophenotypes: BMI and
waist circumference (rP=0.85); systolic BP and diastolic
BP (0.69) (Table 4). Genetic (rG) correlations between
endophenotypes estimated from a multivariate analysis
(Table 5) were similar to the pattern of phenotypic
correlations. Weak to moderate genetic correlations were
observed between endophenotypes, except for correlations
between: BMI and waist circumference (rG=0.85); systolic
BP and diastolic BP (0.69); HDL and TAG (−0.53). Strong
phenotypic and genetic correlations were observed between
obesity-related endophenotypes (BMI and waist circumfer-
ence) and BIGTT indices (Tables 4 and 5). For example, the
phenotypic and genetic correlations between BMI and
BIGTT-SI were −0.67 and −0.73, respectively. However,
these correlations were confounded by the fact that BMI
was part of the equation in the BIGTT indices. Interesting-
ly, moderate negative genetic correlation (−0.47) was
observed between BIGTT-SI and triacylglycerol.
None of the common environmental correlations be-
tween pairs of endophenotypes was significantly different
from zero. The model testing (Table 6) showed that the
cross-trait common environmental correlations can be
dropped from the model (p>0.05). The environmental
correlations between a pair of endophenotypes were mostly
due to individual environmental effect.
Discussion
We have partitioned the observed phenotypic (co)variation of
endophenotypes associated with the metabolic syndrome in
MZ and DZ twin pairs into genetic and environmental
components. The results showed that genetic factors largely
contributed to the individual differences in most endopheno-
types. At the same time, the results showed that the
endophenotypes related to the metabolic syndrome do not
seem to share major common genetic or familial environmen-
tal backgrounds, except for the correlations between BIGTT
indices and obesity endophenotypes and BIGTT-SI and TAG.
As with any other twin studies, this study should be
viewed in the presence of the potential limitations, including
whether twins under study are representative of the general
population of singleton births. In our study, there is no
reason to believe that twins are different from the general
population, as we have found the same prevalence of a
number of diseases, e.g. type 1 and type 2 diabetes, thyroid
diseases, skin diseases and mortality, in Danish twins as in
the population (reference list available from K. O. Kyvik). In
addition to that, twin studies assume that MZ and DZ twins
share the same common environmental experiences. This
assumption can be tested by comparing phenotypic similar-
ity in twins of perceived versus true zygosity [28, 29]. The
assumption is violated if the phenotypic similarity of the
twins is the result of perceived zygosity rather than of true
Table 5 Genetic (upper diagonal) and specific environmental (lower diagonal) correlations from a multivariate (full ACE) model between
endophenotypes associated with the metabolic syndrome
Endophenotypes BMI Waist circumference SBP DBP HDL LDL TAG BIGTT-SI BIGTT-AIR
BMI 0.85 0.26 0.32 −0.08 0.03 0.04 −0.73 0.51
Waist circumference 0.88 0.20 0.27 0.03 0.01 0.03 −0.64 0.47
BP
Systolic 0.27 0.21 0.69 −0.01 0.07 0.21 −0.27 0.28
Diastolic 0.26 0.20 0.74 −0.13 0.10 0.10 −0.23 0.23
HDL −0.20 −0.22 0.11 0.12 −0.08 −0.53 0.16 0.01
LDL 0.24 0.23 0.08 0.07 −0.20 0.38 −0.12 0.10
TAG 0.35 0.35 0.16 0.19 −0.15 0.14 −0.47 0.01
BIGTT-SI −0.67 −0.59 −0.26 −0.24 0.12 −0.13 −0.34 −0.53
BIGTT-AIR 0.44 0.37 0.11 0.15 −0.15 0.05 0.23 −0.42
Table 6 Goodness of fit statistics from multivariate analyses of the endophenotypes related to the metabolic syndrome
Number Model Tested against −2ll df Δ−2ll Δ df p value
1 Full model (ACE) 23,525.1 10,537
2 Drop C (off-diagonal) 1 23,556.6 10,573 31.5 36 0.68
3a Drop all C (AE model) 2 23,571.6 10,582 15 9 0.09
4 Drop A (off-diagonal) 1 23,615.8 10,573 90.7 36 <0.001
−2ll −2 times log-likelihood of data, Δ difference
a The best fitting model
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zygosity. While this assumption has been tested empirically
for some traits [28], this is not commonly practised as part
of most twin studies. A well known bias in twin studies is a
biased sample of MZ and concordant twins. Our sample of
twins originates from a population-based twin registry
without oversampling of MZ pairs; moreover, the sampling
for the study was stratified similarly on age, sex and
zygosity groups and so there is probably no bias due to
oversampling of MZ twin pairs.
It is debatable whether the differences between the older
and younger cohort are of importance for the results. The
younger cohort was selected as self-reported and healthy on
the basis of questionnaire data obtained 3 years before the
study, while these data were not available for the older
cohort. However, both cohorts were screened for known
diabetes and cardiovascular disease before being invited to
this clinical investigation. The non-participation among the
selected and invited twins may have introduced biases in
the distribution of the individual endophenotypes of the
metabolic syndrome, but, although unverifiable, we find it
unlikely that the intrapair correlations and the mutual
relationship between the endophenotypes are biased by this
attrition of the study sample compared with the original
study population.
Multivariate genetic analysis showed that the heritability
estimates for all nine endophenotypes associated with the
metabolic syndrome were moderate to high. These results
indicate that phenotypic variation in individual endopheno-
types is mostly due to genetic effects and this is consistent
with the many univariate analyses published by us and
others [9–13, 23]. Environmental factors contributing to the
variation of the endophenotypes between individuals appear
to be mostly experienced by individuals and not shared
between family members. We have no evidence that our
design and age group are the main reason for small
common environmental variance. But since participants
were older than 18 years (adults), it is possible that
common environmental exposure shared by twin pairs
was less marked than when the twin pairs were young.
Previous twin studies have also shown that phenotypic
variation in most of the metabolic syndrome-related
endophenotypes were largely genetic in origin [13, 16,
30]. Those studies also reported that common environmen-
tal variance shared by family members did not contribute to
the variations of the endophenotypes. Some family studies
reported smaller genetic components influencing phenotyp-
ic variation in the phenotypes related to the metabolic
syndrome [9, 12, 15, 31], but the components were still
significantly different from zero.
By partitioning the phenotypic covariance between
endophenotypes into underlying genetic and environmental
components, multivariate genetic analyses have been useful
for understanding the relationship between the endopheno-
types. The results show that the genetic and phenotypic
correlations between the endophenotypes were strong only
within physiologically similar endophenotypes, but weak to
moderate for other endophenotypes. The strong genetic
correlations between endophenotypes within physiological-
ly similar endophenotypes indicate that these endopheno-
types, as expected, have many genes in common. These
findings may also be due to a direct causal physiological
relationship between these endophenotypes, e.g. insulin–
glucose regulation and its consequences. Multivariate
genetic analysis also showed that environmental factors
common to a pair of endophenotypes were specific to
individuals rather than shared by family members.
While previous studies have suggested common under-
lying factors influencing the endophenotypes related to the
metabolic syndrome [10, 17], genetic, environmental and
phenotypic correlations between groups of endophenotypes
estimated from the present study did not entirely support
this finding. The correlations between endophenotypes
were mostly weak, except moderate correlations between
insulin-related endophenotypes and either obesity or lipid
endophenotypes.
The genetic and environmental correlations estimated
from the present study are mostly in line with previous
studies [12, 16–21]. Moderate correlations between insulin-
related endophenotypes and obesity traits have previously
been reported [16, 18, 19]. For example, using 110 female
twin pairs, Samaras et al. [16] reported a genetic correlation
of 0.41 between insulin resistance and central fat, while
Nelson et al. [18] reported a higher genetic correlation of
0.64 between WHR and fasting insulin. The correlations
between BP and other metabolic syndrome endophenotypes
have been reported to be weak [17, 19], while Mitchell et al.
[31] have reported a near-zero genetic correlation between
fasting insulin with either systolic or diastolic BP. The
correlations between the other metabolic syndrome endo-
phenotypes have also been reported to be weak or moderate
[12, 16, 19–21]. Although the correlations between endo-
phenotypes reported in those studies were similar to those in
the present study, these correlations have mostly been
interpreted as strong evidence of a common underlying
factor influencing the metabolic syndrome.
Knowing that a large proportion of phenotypic variance
of individual endophenotypes of the metabolic syndrome
traits is explained by genetic factors, the next challenge is
to find the genes responsible. Some studies have reported
quantitative trait loci (QTL) responsible for the cluster of
the metabolic syndrome or its components [32–35]. The
BEACON gene (also known as UBL5) located on chromo-
some 19 p has been reported to be associated with the
metabolic syndrome-related endophenotypes [36]. Goldin
et al. [37] summarised 12 studies reporting QTLs related to
the metabolic syndrome components; the QTLs were
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located mostly on chromosomes 1, 3, 5, 6, 7, 10, 14 and 17.
Some studies have tried to locate genes responsible for the
metabolic syndrome as a composite variable [38–41].
Given that genetic correlations between the endopheno-
types of metabolic syndrome were weak to moderate as
suggested from this study, finding genes for the metabolic
syndrome as a composite variable may not be a good strat-
egy. This strategy may be appropriate only for physiologi-
cally similar endophenotypes, where the genetic correlations
are mostly high. Results from our study suggest that it could
be a better option to identify separately the genes responsible
for each component of the endophenotypes of the metabolic
syndrome.
In conclusion, while the individual endophenotypes of
the metabolic syndrome were highly heritable, the weak to
moderate genetic correlations and no significant common
environmental correlations between endophenotypes sug-
gest that the metabolic syndrome comprises a composite set
of endophenotypes, which apparently do not share a
substantial common genetic and familial environmental
background in the general population. However, moderate
genetic correlations between BIGTT-SI and either obesity
endophenotypes or TAG indicate that some common
genetic backgrounds are shared between those components.
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